| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 1.30e-07 | 7 | 158 | 4 | GO:0034988 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 5.35e-07 | 21 | 158 | 5 | GO:0034987 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 1.93e-06 | 4 | 158 | 3 | GO:0030197 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 2.46e-06 | 187 | 158 | 10 | GO:0016922 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | NCOA6 BCAS3 PIAS2 MEF2D MLXIPL BRD8 BAZ2A LRP2 TMF1 IPO13 MMS19 TBX20 PRAME SMAD4 | 6.04e-06 | 417 | 158 | 14 | GO:0061629 |
| GeneOntologyMolecularFunction | IgG receptor activity | 1.66e-05 | 7 | 158 | 3 | GO:0019770 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA6 BCAS3 PIAS2 MEF2D MLXIPL GRHL1 BRD8 BAZ2A LRP2 TMF1 IPO13 MMS19 TBX20 PRAME SMAD4 | 6.17e-05 | 582 | 158 | 15 | GO:0140297 |
| GeneOntologyMolecularFunction | IgG binding | 7.66e-05 | 11 | 158 | 3 | GO:0019864 | |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA6 HNF1A ZBTB16 BCAS3 PIAS2 MEF2D MLXIPL GRHL1 BRD8 BAZ2A LRP2 TMF1 IPO13 MMS19 TBX20 PRAME SMAD4 | 1.01e-04 | 753 | 158 | 17 | GO:0008134 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | HNF1A ZBTB16 MECOM MEF2D PRDM2 MLXIPL GRHL1 GLI1 PLAGL1 ZNF76 DLX2 PAX5 TBX20 SMAD4 | 1.50e-04 | 560 | 158 | 14 | GO:0001228 |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 1.66e-04 | 14 | 158 | 3 | GO:0019763 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | HNF1A ZBTB16 MECOM MEF2D PRDM2 MLXIPL GRHL1 GLI1 PLAGL1 ZNF76 DLX2 PAX5 TBX20 SMAD4 | 1.68e-04 | 566 | 158 | 14 | GO:0001216 |
| GeneOntologyMolecularFunction | low-affinity IgG receptor activity | 3.69e-04 | 4 | 158 | 2 | GO:0019772 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 5.02e-04 | 20 | 158 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA6 NUP98 DCC CBFA2T3 PIAS2 BRD8 ATF7IP HELZ2 TMF1 MMS19 MAML2 MUC1 MRTFA | 5.43e-04 | 562 | 158 | 13 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 7.07e-04 | 303 | 158 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.39e-03 | 61 | 158 | 4 | GO:0030374 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 2.24e-12 | 13 | 158 | 7 | GO:0001788 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 8.28e-12 | 15 | 158 | 7 | GO:0001794 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 8.28e-12 | 15 | 158 | 7 | GO:0002445 | |
| GeneOntologyBiologicalProcess | hypersensitivity | 9.60e-12 | 25 | 158 | 8 | GO:0002524 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 1.51e-11 | 9 | 158 | 6 | GO:0001810 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 3.76e-11 | 10 | 158 | 6 | GO:0016068 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 8.22e-11 | 11 | 158 | 6 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 8.22e-11 | 11 | 158 | 6 | GO:0002892 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to antigenic stimulus | 9.39e-10 | 42 | 158 | 8 | GO:0002438 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 1.36e-09 | 8 | 158 | 5 | GO:0001812 | |
| GeneOntologyBiologicalProcess | regulation of hypersensitivity | 4.59e-09 | 19 | 158 | 6 | GO:0002883 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 6.05e-09 | 10 | 158 | 5 | GO:0001798 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 6.05e-09 | 10 | 158 | 5 | GO:0002894 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to antigenic stimulus | 4.76e-08 | 27 | 158 | 6 | GO:0002864 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 6.99e-08 | 15 | 158 | 5 | GO:0002885 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid leukocyte mediated immunity | 9.37e-08 | 30 | 158 | 6 | GO:0002888 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 1.42e-07 | 17 | 158 | 5 | GO:0002866 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response to antigenic stimulus | 7.45e-07 | 23 | 158 | 5 | GO:0002863 | |
| GeneOntologyBiologicalProcess | inflammatory response to antigenic stimulus | 1.27e-06 | 103 | 158 | 8 | GO:0002437 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte mediated immunity | 2.93e-06 | 81 | 158 | 7 | GO:0002886 | |
| GeneOntologyBiologicalProcess | regulation of inflammatory response to antigenic stimulus | 7.20e-06 | 61 | 158 | 6 | GO:0002861 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 7.92e-06 | 62 | 158 | 6 | GO:0002455 | |
| GeneOntologyBiologicalProcess | positive regulation of phagocytosis | 1.12e-05 | 99 | 158 | 7 | GO:0050766 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response | 1.25e-05 | 67 | 158 | 6 | GO:0002673 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 1.43e-05 | 187 | 158 | 9 | GO:0001909 | |
| GeneOntologyBiologicalProcess | acute inflammatory response | 1.47e-05 | 143 | 158 | 8 | GO:0002526 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 1.48e-05 | 69 | 158 | 6 | GO:0006911 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response | 1.68e-05 | 42 | 158 | 5 | GO:0002675 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 1.68e-05 | 42 | 158 | 5 | GO:0006910 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte mediated immunity | 1.89e-05 | 148 | 158 | 8 | GO:0002444 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 2.99e-05 | 78 | 158 | 6 | GO:0099024 | |
| GeneOntologyBiologicalProcess | regulation of B cell mediated immunity | 3.22e-05 | 79 | 158 | 6 | GO:0002712 | |
| GeneOntologyBiologicalProcess | regulation of immunoglobulin mediated immune response | 3.22e-05 | 79 | 158 | 6 | GO:0002889 | |
| GeneOntologyBiologicalProcess | membrane invagination | 5.56e-05 | 87 | 158 | 6 | GO:0010324 | |
| GeneOntologyBiologicalProcess | endocytic hemoglobin import into cell | 5.83e-05 | 2 | 158 | 2 | GO:0020028 | |
| GeneOntologyBiologicalProcess | negative regulation of type I hypersensitivity | 5.83e-05 | 2 | 158 | 2 | GO:0001811 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell mediated immunity | 6.90e-05 | 56 | 158 | 5 | GO:0002714 | |
| GeneOntologyBiologicalProcess | positive regulation of immunoglobulin mediated immune response | 6.90e-05 | 56 | 158 | 5 | GO:0002891 | |
| GeneOntologyBiologicalProcess | regulation of phagocytosis | 8.65e-05 | 136 | 158 | 7 | GO:0050764 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 9.94e-05 | 187 | 158 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA6 HNF1A ZBTB16 BCAS3 MECOM MEF2D PRDM2 MLXIPL GRHL1 BRD8 ZNF827 GLI1 EPC1 HELZ2 TMF1 PLAGL1 ZNF76 DLX2 PAX5 MAML2 TBX20 MUC1 MRTFA SMAD4 | 1.51e-04 | 1390 | 158 | 24 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of endocytosis | 2.43e-04 | 213 | 158 | 8 | GO:0045807 | |
| GeneOntologyBiologicalProcess | regulation of B cell activation | 2.66e-04 | 163 | 158 | 7 | GO:0050864 | |
| GeneOntologyBiologicalProcess | heart valve formation | 2.77e-04 | 17 | 158 | 3 | GO:0003188 | |
| GeneOntologyBiologicalProcess | condensed mesenchymal cell proliferation | 3.46e-04 | 4 | 158 | 2 | GO:0072137 | |
| GeneOntologyBiologicalProcess | negative regulation of hypersensitivity | 3.46e-04 | 4 | 158 | 2 | GO:0002884 | |
| GeneOntologyBiologicalProcess | B cell receptor signaling pathway | 3.53e-04 | 79 | 158 | 5 | GO:0050853 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 3.54e-04 | 44 | 158 | 4 | GO:0006958 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 4.30e-04 | 232 | 158 | 8 | GO:0002706 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 4.69e-04 | 235 | 158 | 8 | GO:0002822 | |
| GeneOntologyBiologicalProcess | folate transmembrane transport | 5.74e-04 | 5 | 158 | 2 | GO:0098838 | |
| GeneOntologyBiologicalProcess | regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway | 5.74e-04 | 5 | 158 | 2 | GO:1903381 | |
| GeneOntologyBiologicalProcess | negative regulation of neutrophil apoptotic process | 5.74e-04 | 5 | 158 | 2 | GO:0033030 | |
| GeneOntologyBiologicalProcess | early endosome to late endosome transport | 5.80e-04 | 50 | 158 | 4 | GO:0045022 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB6 CYLD DCHS2 CDH26 ZBTB16 PCDHGA1 PKP4 ICAM3 CDH23 DCC CDH19 LRRC4 ARG1 HMCN1 DCHS1 IGSF9B CTNND2 MUC4 CD200 | 6.01e-04 | 1077 | 158 | 19 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell killing | 6.17e-04 | 307 | 158 | 9 | GO:0001906 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 7.09e-04 | 313 | 158 | 9 | GO:0098742 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 7.14e-04 | 139 | 158 | 6 | GO:0019882 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 7.25e-04 | 53 | 158 | 4 | GO:0016339 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 7.41e-04 | 252 | 158 | 8 | GO:0002819 | |
| GeneOntologyBiologicalProcess | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 8.57e-04 | 6 | 158 | 2 | GO:0036483 | |
| GeneOntologyBiologicalProcess | hemidesmosome assembly | 8.57e-04 | 6 | 158 | 2 | GO:0031581 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport between endosomal compartments | 8.93e-04 | 56 | 158 | 4 | GO:0098927 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 9.28e-04 | 201 | 158 | 7 | GO:0030183 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | RALGAPA1 HNF1A ZBTB16 MECOM CBFA2T3 ZHX2 PRDM2 MLXIPL ZNF827 BAZ2A ATF7IP EPC1 PLAGL1 DLX2 PAX5 MAGEC1 TBX20 MBD2 MUC1 PRAME PRDM6 SMAD4 | 1.02e-03 | 1399 | 158 | 22 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | RALGAPA1 HNF1A ZBTB16 MECOM CBFA2T3 ZHX2 PRDM2 MLXIPL ZNF827 BAZ2A ATF7IP EPC1 PLAGL1 DLX2 PAX5 MAGEC1 TBX20 MBD2 MUC1 PRAME PRDM6 SMAD4 | 1.16e-03 | 1413 | 158 | 22 | GO:1902679 |
| GeneOntologyCellularComponent | Golgi lumen | 1.60e-07 | 109 | 160 | 9 | GO:0005796 | |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 3.12e-06 | 14 | 160 | 4 | GO:0071735 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 7.28e-06 | 17 | 160 | 4 | GO:0042571 | |
| GeneOntologyCellularComponent | catenin complex | 1.01e-04 | 32 | 160 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | cell surface | EPHB6 AQP11 MXRA8 MUC16 CP CUBN DCC PKD1L3 FCGR2C FCGR2A FCGR2B MUC17 IGHG1 IGHG2 IGHG3 IGHG4 LRP2 CAPN5 MUC1 CD200 | 3.29e-04 | 1111 | 160 | 20 | GO:0009986 |
| GeneOntologyCellularComponent | apical part of cell | SLC5A10 CDH23 ABCC5 CUBN SLC9A4 KCNE4 MUC17 DCHS1 LRP2 MTCL1 MUC1 MUC4 SLC4A11 | 6.50e-04 | 592 | 160 | 13 | GO:0045177 |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 6.59e-04 | 137 | 160 | 6 | GO:0019897 | |
| GeneOntologyCellularComponent | side of membrane | CYLD CDIP1 PKP4 MUC16 CUBN FCGR2C DST FCGR2A FCGR2B MUC17 IGHG1 IGHG2 IGHG3 IGHG4 FARP1 LRP2 | 1.13e-03 | 875 | 160 | 16 | GO:0098552 |
| MousePheno | absent memory B cells | 6.71e-09 | 4 | 128 | 4 | MP:0008094 | |
| MousePheno | increased IgG2b level | 2.12e-07 | 47 | 128 | 7 | MP:0008501 | |
| MousePheno | increased germinal center B cell number | 3.20e-07 | 31 | 128 | 6 | MP:0008177 | |
| MousePheno | decreased memory B cell number | 8.16e-07 | 9 | 128 | 4 | MP:0008729 | |
| MousePheno | decreased IgG2c level | 2.11e-06 | 11 | 128 | 4 | MP:0008897 | |
| MousePheno | abnormal memory B cell number | 2.11e-06 | 11 | 128 | 4 | MP:0008093 | |
| MousePheno | increased susceptibility to type I hypersensitivity reaction | 2.42e-06 | 43 | 128 | 6 | MP:0005596 | |
| MousePheno | increased IgG2a level | 4.95e-06 | 74 | 128 | 7 | MP:0008500 | |
| MousePheno | abnormal memory B cell morphology | 6.25e-06 | 14 | 128 | 4 | MP:0002440 | |
| MousePheno | abnormal plasma cell differentiation | 8.47e-06 | 15 | 128 | 4 | MP:0008099 | |
| MousePheno | abnormal IgG2b level | 9.69e-06 | 114 | 128 | 8 | MP:0020177 | |
| MousePheno | abnormal germinal center B cell number | 1.05e-05 | 55 | 128 | 6 | MP:0013680 | |
| MousePheno | abnormal germinal center B cell morphology | 1.05e-05 | 55 | 128 | 6 | MP:0008176 | |
| MousePheno | increased IgG1 level | 1.07e-05 | 83 | 128 | 7 | MP:0008499 | |
| MousePheno | enhanced humoral immune response | 1.46e-05 | 17 | 128 | 4 | MP:0020155 | |
| MousePheno | abnormal IgG1 level | 1.50e-05 | 200 | 128 | 10 | MP:0020175 | |
| MousePheno | increased mature B cell number | 2.37e-05 | 168 | 128 | 9 | MP:0008210 | |
| MousePheno | increased autoantibody level | 2.98e-05 | 133 | 128 | 8 | MP:0003725 | |
| MousePheno | increased IgG2 level | 3.39e-05 | 99 | 128 | 7 | MP:0013803 | |
| MousePheno | abnormal IgG2c level | 3.56e-05 | 21 | 128 | 4 | MP:0020178 | |
| MousePheno | increased anti-double stranded DNA antibody level | 4.25e-05 | 70 | 128 | 6 | MP:0004762 | |
| MousePheno | abnormal IgG2a level | 6.71e-05 | 149 | 128 | 8 | MP:0020176 | |
| MousePheno | increased anti-nuclear antigen antibody level | 8.84e-05 | 115 | 128 | 7 | MP:0004794 | |
| MousePheno | abnormal type I hypersensitivity reaction | 1.19e-04 | 84 | 128 | 6 | MP:0002531 | |
| MousePheno | decreased IgG1 level | 1.73e-04 | 128 | 128 | 7 | MP:0008495 | |
| MousePheno | decreased B cell apoptosis | 2.54e-04 | 14 | 128 | 3 | MP:0008783 | |
| MousePheno | abnormal mature B cell morphology | 4.08e-04 | 244 | 128 | 9 | MP:0008171 | |
| MousePheno | abnormal IgG2 level | 4.56e-04 | 197 | 128 | 8 | MP:0013802 | |
| MousePheno | increased plasma cell number | 4.75e-04 | 40 | 128 | 4 | MP:0008097 | |
| MousePheno | increased IgG level | 5.21e-04 | 201 | 128 | 8 | MP:0002493 | |
| Domain | SEA | 2.88e-08 | 23 | 157 | 6 | PS50024 | |
| Domain | SEA_dom | 2.88e-08 | 23 | 157 | 6 | IPR000082 | |
| Domain | SEA | 7.42e-08 | 14 | 157 | 5 | SM00200 | |
| Domain | SEA | 9.24e-07 | 22 | 157 | 5 | PF01390 | |
| Domain | IG_LIKE | MYBPH HSPG2 ICAM3 MXRA8 DCC LRRC4 HMCN1 FCGR2A FCGR2B IGHG1 IGHG2 IGHG3 IGHG4 IGSF9B CD200 | 1.74e-05 | 491 | 157 | 15 | PS50835 |
| Domain | Ig-like_dom | MYBPH HSPG2 ICAM3 MXRA8 DCC LRRC4 HMCN1 FCGR2A FCGR2B IGHG1 IGHG2 IGHG3 IGHG4 IGSF9B CD200 | 2.31e-05 | 503 | 157 | 15 | IPR007110 |
| Domain | Ig-like_fold | MYBPH EPHB6 PLXNA3 HSPG2 ICAM3 MXRA8 DCC LRRC4 HMCN1 FCGR2A FCGR2B IGHG1 IGHG2 IGHG3 IGHG4 ATF7IP IGSF9B CD200 | 2.80e-05 | 706 | 157 | 18 | IPR013783 |
| Domain | DUF3827 | 7.02e-05 | 2 | 157 | 2 | PF12877 | |
| Domain | DUF3827 | 7.02e-05 | 2 | 157 | 2 | IPR024606 | |
| Domain | - | 2.46e-04 | 15 | 157 | 3 | 3.30.70.960 | |
| Domain | BROMODOMAIN_1 | 2.56e-04 | 37 | 157 | 4 | PS00633 | |
| Domain | Bromodomain | 2.84e-04 | 38 | 157 | 4 | PF00439 | |
| Domain | Cadherin_CS | 3.18e-04 | 109 | 157 | 6 | IPR020894 | |
| Domain | BROMODOMAIN_2 | 3.82e-04 | 41 | 157 | 4 | PS50014 | |
| Domain | CADHERIN_1 | 3.86e-04 | 113 | 157 | 6 | PS00232 | |
| Domain | Cadherin | 3.86e-04 | 113 | 157 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 4.05e-04 | 114 | 157 | 6 | PS50268 | |
| Domain | - | 4.05e-04 | 114 | 157 | 6 | 2.60.40.60 | |
| Domain | Bromodomain | 4.19e-04 | 42 | 157 | 4 | IPR001487 | |
| Domain | BROMO | 4.19e-04 | 42 | 157 | 4 | SM00297 | |
| Domain | - | 4.19e-04 | 42 | 157 | 4 | 1.20.920.10 | |
| Domain | IGv | 4.23e-04 | 75 | 157 | 5 | SM00406 | |
| Domain | CA | 4.24e-04 | 115 | 157 | 6 | SM00112 | |
| Domain | Cadherin-like | 4.45e-04 | 116 | 157 | 6 | IPR015919 | |
| Domain | Cadherin | 4.87e-04 | 118 | 157 | 6 | IPR002126 | |
| Domain | - | 5.89e-04 | 222 | 157 | 8 | 1.25.10.10 | |
| Domain | CUB | 7.59e-04 | 49 | 157 | 4 | PF00431 | |
| Domain | CUB | 8.19e-04 | 50 | 157 | 4 | SM00042 | |
| Domain | IGc2 | 8.54e-04 | 235 | 157 | 8 | SM00408 | |
| Domain | Ig_sub2 | 8.54e-04 | 235 | 157 | 8 | IPR003598 | |
| Domain | IG | MYBPH HSPG2 ICAM3 MXRA8 DCC LRRC4 HMCN1 FCGR2A FCGR2B IGSF9B CD200 | 8.84e-04 | 421 | 157 | 11 | SM00409 |
| Domain | Ig_sub | MYBPH HSPG2 ICAM3 MXRA8 DCC LRRC4 HMCN1 FCGR2A FCGR2B IGSF9B CD200 | 8.84e-04 | 421 | 157 | 11 | IPR003599 |
| Domain | - | 9.51e-04 | 52 | 157 | 4 | 2.60.120.290 | |
| Domain | Sushi | 9.51e-04 | 52 | 157 | 4 | PF00084 | |
| Domain | CUB | 1.02e-03 | 53 | 157 | 4 | PS01180 | |
| Domain | C1-set | 1.10e-03 | 54 | 157 | 4 | PF07654 | |
| Domain | CCP | 1.10e-03 | 54 | 157 | 4 | SM00032 | |
| Domain | ig | 1.14e-03 | 190 | 157 | 7 | PF00047 | |
| Domain | Immunoglobulin | 1.14e-03 | 190 | 157 | 7 | IPR013151 | |
| Domain | SUSHI | 1.26e-03 | 56 | 157 | 4 | PS50923 | |
| Domain | IGc1 | 1.26e-03 | 56 | 157 | 4 | SM00407 | |
| Domain | Sushi_SCR_CCP_dom | 1.34e-03 | 57 | 157 | 4 | IPR000436 | |
| Domain | CUB_dom | 1.34e-03 | 57 | 157 | 4 | IPR000859 | |
| Domain | Ig/MHC_CS | 1.43e-03 | 58 | 157 | 4 | IPR003006 | |
| Domain | Ig_C1-set | 1.43e-03 | 58 | 157 | 4 | IPR003597 | |
| Domain | Plakophilin/d_Catenin | 1.43e-03 | 7 | 157 | 2 | IPR028435 | |
| Domain | - | MYBPH EPHB6 PLXNA3 HSPG2 ICAM3 MXRA8 DCC LRRC4 HMCN1 FCGR2A FCGR2B ATF7IP IGSF9B CD200 | 1.44e-03 | 663 | 157 | 14 | 2.60.40.10 |
| Domain | EGF_1 | 1.44e-03 | 255 | 157 | 8 | PS00022 | |
| Domain | IG_MHC | 1.63e-03 | 60 | 157 | 4 | PS00290 | |
| Domain | EGF-like_CS | 1.67e-03 | 261 | 157 | 8 | IPR013032 | |
| Domain | EGF_2 | 1.83e-03 | 265 | 157 | 8 | PS01186 | |
| Domain | - | 1.90e-03 | 8 | 157 | 2 | 3.30.890.10 | |
| Domain | ARM-like | 2.06e-03 | 270 | 157 | 8 | IPR011989 | |
| Domain | ARM-type_fold | 2.32e-03 | 339 | 157 | 9 | IPR016024 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 9.80e-12 | 16 | 103 | 7 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.66e-11 | 17 | 103 | 7 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.01e-10 | 23 | 103 | 7 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 5.31e-10 | 26 | 103 | 7 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 3.20e-07 | 62 | 103 | 7 | M546 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.50e-07 | 21 | 103 | 5 | MM15706 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 6.09e-07 | 68 | 103 | 7 | M27303 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 8.26e-07 | 140 | 103 | 9 | M27484 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 1.26e-06 | 48 | 103 | 6 | MM17214 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 3.17e-06 | 56 | 103 | 6 | MM14815 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 9.73e-06 | 143 | 103 | 8 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.65e-05 | 111 | 103 | 7 | M27416 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 7.50e-05 | 60 | 103 | 5 | MM15636 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 8.84e-05 | 250 | 103 | 9 | M27554 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 1.82e-04 | 39 | 103 | 4 | MM17212 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 1.85e-04 | 114 | 103 | 6 | MM14814 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 6.42e-04 | 54 | 103 | 4 | MM14655 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 8.23e-15 | 18 | 163 | 8 | 18834073 | |
| Pubmed | 6.74e-14 | 7 | 163 | 6 | 15100265 | ||
| Pubmed | 6.74e-14 | 7 | 163 | 6 | 10395649 | ||
| Pubmed | 8.02e-13 | 9 | 163 | 6 | 22922409 | ||
| Pubmed | Inhibitory Fcγ receptor is required for the maintenance of tolerance through distinct mechanisms. | 8.02e-13 | 9 | 163 | 6 | 24563255 | |
| Pubmed | Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. | 8.02e-13 | 9 | 163 | 6 | 8552190 | |
| Pubmed | 8.02e-13 | 9 | 163 | 6 | 25404305 | ||
| Pubmed | Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. | 2.00e-12 | 10 | 163 | 6 | 8769481 | |
| Pubmed | 2.13e-12 | 5 | 163 | 5 | 9834201 | ||
| Pubmed | Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). | 2.13e-12 | 5 | 163 | 5 | 9743367 | |
| Pubmed | 4.38e-12 | 11 | 163 | 6 | 11911824 | ||
| Pubmed | 4.38e-12 | 11 | 163 | 6 | 16492738 | ||
| Pubmed | 1.18e-10 | 8 | 163 | 5 | 21037092 | ||
| Pubmed | MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. | 1.18e-10 | 8 | 163 | 5 | 30205047 | |
| Pubmed | 1.18e-10 | 8 | 163 | 5 | 38579014 | ||
| Pubmed | FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo. | 2.64e-10 | 9 | 163 | 5 | 20974962 | |
| Pubmed | Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain. | 4.65e-10 | 4 | 163 | 4 | 113776 | |
| Pubmed | Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. | 4.65e-10 | 4 | 163 | 4 | 11812141 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 6794027 | ||
| Pubmed | Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes. | 4.65e-10 | 4 | 163 | 4 | 2510996 | |
| Pubmed | Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection. | 4.65e-10 | 4 | 163 | 4 | 1754385 | |
| Pubmed | Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies. | 4.65e-10 | 4 | 163 | 4 | 19050247 | |
| Pubmed | An autoimmune disease variant of IgG1 modulates B cell activation and differentiation. | 4.65e-10 | 4 | 163 | 4 | 30287618 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 7892607 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 4565406 | ||
| Pubmed | IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. | 4.65e-10 | 4 | 163 | 4 | 25363774 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 20621099 | ||
| Pubmed | Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). | 4.65e-10 | 4 | 163 | 4 | 12414967 | |
| Pubmed | Shutdown of class switch recombination by deletion of a switch region control element. | 4.65e-10 | 4 | 163 | 4 | 8438159 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 4098598 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 6253932 | ||
| Pubmed | Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. | 4.65e-10 | 4 | 163 | 4 | 6769752 | |
| Pubmed | Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes. | 4.65e-10 | 4 | 163 | 4 | 6803173 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 6264445 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 2878362 | ||
| Pubmed | IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice. | 4.65e-10 | 4 | 163 | 4 | 25867470 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 1542303 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 9725203 | ||
| Pubmed | Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains. | 4.65e-10 | 4 | 163 | 4 | 9126488 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 8452816 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 4831970 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 7439686 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 6278424 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 35133976 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 8099342 | ||
| Pubmed | Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation. | 4.65e-10 | 4 | 163 | 4 | 32006024 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 12209645 | ||
| Pubmed | Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain. | 4.65e-10 | 4 | 163 | 4 | 117549 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 116231 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 25451975 | ||
| Pubmed | Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains. | 4.65e-10 | 4 | 163 | 4 | 6283537 | |
| Pubmed | Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain. | 4.65e-10 | 4 | 163 | 4 | 6801765 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 6306571 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 1672339 | ||
| Pubmed | Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. | 4.65e-10 | 4 | 163 | 4 | 1713710 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 6777755 | ||
| Pubmed | The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. | 4.65e-10 | 4 | 163 | 4 | 9103199 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 6297797 | ||
| Pubmed | Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain. | 4.65e-10 | 4 | 163 | 4 | 98524 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 38268239 | ||
| Pubmed | Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains. | 4.65e-10 | 4 | 163 | 4 | 6799207 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 6787604 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 6170065 | ||
| Pubmed | Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. | 4.65e-10 | 4 | 163 | 4 | 19703988 | |
| Pubmed | Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch. | 4.65e-10 | 4 | 163 | 4 | 6767246 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 12051834 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 8683112 | ||
| Pubmed | Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. | 4.65e-10 | 4 | 163 | 4 | 807855 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 4166666 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 26201558 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 6249338 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 6804950 | ||
| Pubmed | Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. | 4.65e-10 | 4 | 163 | 4 | 19592272 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 10720538 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 24752300 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 15699144 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 2513486 | ||
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 36763580 | ||
| Pubmed | Independent immunoglobulin class-switch events occurring in a single myeloma cell line. | 4.65e-10 | 4 | 163 | 4 | 3921826 | |
| Pubmed | 4.65e-10 | 4 | 163 | 4 | 6262729 | ||
| Pubmed | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. | 4.65e-10 | 4 | 163 | 4 | 26683050 | |
| Pubmed | Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA. | 4.65e-10 | 4 | 163 | 4 | 6766534 | |
| Pubmed | TTC28 ZGRF1 MECOM PIAS2 PRDM2 GREB1L DST WDR6 ATF7IP LRP2 TMF1 RAI14 MRTFA KIF11 KNL1 | 1.46e-09 | 418 | 163 | 15 | 34709266 | |
| Pubmed | Exon shuffling generates an immunoglobulin heavy chain gene. | 2.32e-09 | 5 | 163 | 4 | 6769120 | |
| Pubmed | Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains. | 2.32e-09 | 5 | 163 | 4 | 6770027 | |
| Pubmed | Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies. | 2.32e-09 | 5 | 163 | 4 | 7704573 | |
| Pubmed | Channel catfish soluble FcmuR binds conserved linear epitopes present on Cmu3 and Cmu4. | 2.32e-09 | 5 | 163 | 4 | 20031218 | |
| Pubmed | A novel allele for inducible Cre expression in germinal center BÂ cells. | 2.32e-09 | 5 | 163 | 4 | 30359469 | |
| Pubmed | 2.32e-09 | 5 | 163 | 4 | 103631 | ||
| Pubmed | 2.32e-09 | 5 | 163 | 4 | 33163250 | ||
| Pubmed | 2.32e-09 | 5 | 163 | 4 | 37310381 | ||
| Pubmed | 2.32e-09 | 5 | 163 | 4 | 36853944 | ||
| Pubmed | 2.32e-09 | 5 | 163 | 4 | 23423996 | ||
| Pubmed | The disulphide bridges of a mouse immunoglobulin G1 protein. | 2.32e-09 | 5 | 163 | 4 | 5073237 | |
| Pubmed | Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma. | 2.32e-09 | 5 | 163 | 4 | 35044826 | |
| Pubmed | Sequential class switching is required for the generation of high affinity IgE antibodies. | 2.32e-09 | 5 | 163 | 4 | 22249450 | |
| Pubmed | The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program. | 2.32e-09 | 5 | 163 | 4 | 26620759 | |
| Pubmed | 2.32e-09 | 5 | 163 | 4 | 32640012 | ||
| Pubmed | 2.32e-09 | 5 | 163 | 4 | 32229726 | ||
| Pubmed | Brg1 Supports B Cell Proliferation and Germinal Center Formation Through Enhancer Activation. | 2.32e-09 | 5 | 163 | 4 | 34539636 | |
| Interaction | HDAC1 interactions | ZBTB16 TTC28 BCAS3 ZGRF1 NUP98 MECOM BIRC3 PSMD2 CBFA2T3 ZHX2 MEF2D DST ZNF827 BAZ2A WDR6 GLI1 MKI67 TMF1 PLAGL1 ZNF76 RAI14 MBD2 PRDM6 MRTFA SMAD4 KNL1 | 6.42e-07 | 1108 | 160 | 26 | int:HDAC1 |
| GeneFamily | CD molecules|Mucins | 4.34e-15 | 21 | 118 | 9 | 648 | |
| GeneFamily | Cadherin related | 1.72e-04 | 17 | 118 | 3 | 24 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 1.72e-04 | 17 | 118 | 3 | 1197 | |
| GeneFamily | Immunoglobulin like domain containing | 2.75e-04 | 193 | 118 | 7 | 594 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.22e-04 | 57 | 118 | 4 | 1179 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.58e-04 | 161 | 118 | 6 | 593 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.40e-03 | 34 | 118 | 3 | 487 | |
| GeneFamily | UPF1 like RNA helicases | 2.24e-03 | 11 | 118 | 2 | 1169 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 2.24e-03 | 11 | 118 | 2 | 1025 | |
| GeneFamily | Low density lipoprotein receptors | 3.14e-03 | 13 | 118 | 2 | 634 | |
| GeneFamily | Fibronectin type III domain containing | 4.00e-03 | 160 | 118 | 5 | 555 | |
| GeneFamily | Aminopeptidases|CD molecules | 5.39e-03 | 17 | 118 | 2 | 104 | |
| Coexpression | NABA_ECM_AFFILIATED | PLXNA3 MUC16 MUC5B MUC12 OVGP1 MUC17 MUC22 MUC1 MUC3A MUC4 PARM1 | 9.47e-09 | 170 | 162 | 11 | M5880 |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | CYLD HNF1A ZBTB16 NUP98 MECOM BIRC3 CBFA2T3 FCGR2B PAX5 MAML2 MUC1 SMAD4 KNL1 | 1.19e-07 | 323 | 162 | 13 | M9150 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SASH1 TTC28 PKP4 NUP98 MECOM ZHX2 MAST2 FAM171A1 DST FAM168A OTUD4 TMEM131 BICRAL MTCL1 WDFY3 MBD2 MRTFA KIF11 SMAD4 SAMD4A | 3.64e-07 | 856 | 162 | 20 | M4500 |
| Coexpression | NABA_ECM_AFFILIATED | 6.57e-06 | 158 | 162 | 8 | MM17063 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5 | SASH1 ABCC5 WLS GREB1L ZNF827 TMF1 RIPOR1 CTNND2 MUC1 SLC4A11 PARM1 SAMD4A BRWD1 | 1.23e-05 | 491 | 162 | 13 | M13661 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | PLXNA3 NCOA6 ABCC5 FEM1C ZHX2 MEF2D DST BAZ2A ATF7IP TMF1 PCNX1 RIPOR1 WDFY3 PRRC2B MRTFA SMAD4 BRWD1 | 1.43e-05 | 822 | 162 | 17 | M6782 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.45e-05 | 176 | 162 | 8 | M39223 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CYLD PLXNA3 LRP12 KIAA1549 ABCC5 DCC CSMD2 CSMD3 PIAS2 PRDM2 KIAA1549L OTUD4 PAPPA IGSF9B PAX5 CTNND2 ADGRD1 PRRC2B XPR1 BRWD1 | 1.72e-05 | 1106 | 162 | 20 | M39071 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.86e-05 | 300 | 162 | 10 | M8702 | |
| Coexpression | LAKE_ADULT_KIDNEY_C1_EPITHELIAL_CELLS_UNASSIGNED | 3.40e-05 | 30 | 162 | 4 | M39220 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP | 3.49e-05 | 199 | 162 | 8 | M3641 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | MXRA8 NUP98 MAST2 NPEPL1 LCMT2 MLXIPL FCGR2C IGHG1 ATF7IP MKI67 STARD3 ZNF76 RAI14 WDFY3 CTNND2 MUC1 MUC4 | 5.08e-05 | 909 | 162 | 17 | M41018 |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP | 6.14e-05 | 159 | 162 | 7 | MM777 | |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | CYLD SASH1 FSIP1 ABCC5 WLS GREB1L ZNF827 RIPOR1 MUC1 PRAME SLC4A11 PARM1 SAMD4A | 7.22e-05 | 583 | 162 | 13 | M17454 |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_DN | 8.54e-05 | 226 | 162 | 8 | M11238 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | CSMD2 WLS LRRC4 CSMD3 PIAS2 MKI67 LRP2 IGSF9B MAML2 CTNND2 KIF11 | 9.54e-05 | 439 | 162 | 11 | M39054 |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 1.16e-04 | 176 | 162 | 7 | M2981 | |
| Coexpression | GCNP_SHH_UP_LATE.V1_DN | 1.25e-04 | 178 | 162 | 7 | M2640 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | FSIP1 ABCC5 CP DCC GRHL1 DST IGHG1 IGHG2 IGHG3 IGHG4 HELZ2 PLAGL1 XPR1 | 1.25e-04 | 616 | 162 | 13 | MM977 |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | WLS ARG1 FCGR2A FCGR2B IGHG1 IGHG2 IGHG3 IGHG4 LRP2 CTNND2 MUC1 PARM1 | 1.28e-04 | 534 | 162 | 12 | MM1050 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.34e-04 | 180 | 162 | 7 | M8239 | |
| Coexpression | VANASSE_BCL2_TARGETS_UP | 1.44e-04 | 43 | 162 | 4 | MM799 | |
| Coexpression | BHAT_ESR1_TARGETS_VIA_AKT1_DN | 1.58e-04 | 82 | 162 | 5 | M2235 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_UP | 1.69e-04 | 187 | 162 | 7 | MM1034 | |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_6 | 1.75e-04 | 132 | 162 | 6 | MM996 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL | 1.80e-04 | 189 | 162 | 7 | M45678 | |
| Coexpression | HEVNER_CORTICAL_PLATE_POSTMITOTIC_NEURONS | 2.06e-04 | 136 | 162 | 6 | MM407 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 | 2.09e-04 | 19 | 162 | 3 | M13194 | |
| Coexpression | GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP | 2.12e-04 | 194 | 162 | 7 | M4958 | |
| Coexpression | GSE29618_BCELL_VS_PDC_UP | 2.25e-04 | 196 | 162 | 7 | M4940 | |
| Coexpression | GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP | 2.40e-04 | 198 | 162 | 7 | M5544 | |
| Coexpression | HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_UP | 2.40e-04 | 49 | 162 | 4 | M41093 | |
| Coexpression | GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN | 2.47e-04 | 199 | 162 | 7 | M8211 | |
| Coexpression | GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP | 2.47e-04 | 199 | 162 | 7 | M7325 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 2.47e-04 | 199 | 162 | 7 | M5235 | |
| Coexpression | GSE45365_NK_CELL_VS_CD11B_DC_UP | 2.47e-04 | 199 | 162 | 7 | M10030 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 2.47e-04 | 199 | 162 | 7 | M6987 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 2.55e-04 | 200 | 162 | 7 | M291 | |
| Coexpression | GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN | 2.55e-04 | 200 | 162 | 7 | M9335 | |
| Coexpression | GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN | 2.55e-04 | 200 | 162 | 7 | M6552 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN | 2.55e-04 | 200 | 162 | 7 | M6583 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 2.70e-04 | 143 | 162 | 6 | MM1056 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PLASMA_CELLS | 2.84e-04 | 21 | 162 | 3 | M39281 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 2.91e-04 | 145 | 162 | 6 | M1810 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_UP | 3.02e-04 | 146 | 162 | 6 | MM964 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | ZBTB16 COL17A1 ABCC5 IRAG1 NACAD ZNF106 GRHL1 KCNE4 DST CLCA2 OTUD4 PAPPA CAPN5 CTNND2 TBX20 ADGRD1 PARM1 SAMD4A | 2.02e-05 | 772 | 159 | 18 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#4 | 2.86e-05 | 24 | 159 | 4 | Arv_SC-H9hpx_500_K4 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | COL17A1 MECOM BIRC3 CP MUC5B HMCN1 IGHG1 IGHG3 IGHG4 PAPPA MUC3A MUC4 PARM1 | 4.63e-13 | 197 | 163 | 13 | 5e0d222872a25bb9e9069d3dffda2844bb69874a |
| ToppCell | Club_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.21e-09 | 138 | 163 | 9 | 133015953fc660d00339f47b415da5e9872313a2 | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.60e-09 | 193 | 163 | 10 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.74e-09 | 194 | 163 | 10 | b16b96e42ea9734731342d4c41ff1711bd149462 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.88e-09 | 195 | 163 | 10 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-B|Bac-SEP / Disease, condition lineage and cell class | BIRC3 C11orf24 FCGR2B IGHG1 IGHG2 IGHG3 IGHG4 PAX5 PARM1 CD200 | 3.50e-09 | 199 | 163 | 10 | 1f4c9f4d227c79628de1f6c3fc05ab10217504a9 |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B|COVID-19_Mild / Disease, condition lineage and cell class | 3.67e-09 | 200 | 163 | 10 | 11b51dfca161342d92126e0a83d10864348ba3ef | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 9.56e-09 | 163 | 163 | 9 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 9.56e-09 | 163 | 163 | 9 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| ToppCell | Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, Lineage and Cell Type | 1.24e-08 | 168 | 163 | 9 | 5b3fb1fc8fea810c6d4e6feb42c24fb57e8066de | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-08 | 171 | 163 | 9 | 13126a3fbee181412c13ffb0c347277b9d8f16f7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.16e-08 | 179 | 163 | 9 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-08 | 180 | 163 | 9 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-08 | 180 | 163 | 9 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | Control-Lymphoid-B|World / Disease state, Lineage and Cell class | 2.37e-08 | 181 | 163 | 9 | 9124f1a610cfc3355ad87921cd3eb5346956475d | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 2.74e-08 | 184 | 163 | 9 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | ILEUM-non-inflamed-(5)_IgG_plasma_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.87e-08 | 185 | 163 | 9 | 93b9a47357152ea95dfdfe8e7d111906a4adc551 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 3.00e-08 | 186 | 163 | 9 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.15e-08 | 187 | 163 | 9 | 8089ae6ee59533a090fe0b19bdd057fba8fa11de | |
| ToppCell | Healthy_donor-B_memory|World / disease group, cell group and cell class (v2) | 3.15e-08 | 187 | 163 | 9 | 4f68e3243071a4549c80aff8bff32c6ad892ee7f | |
| ToppCell | Bac-SEP-Lymphocyte-B|Bac-SEP / Disease, Lineage and Cell Type | 3.15e-08 | 187 | 163 | 9 | 027aa7b5be402fc82ae13c346dfb4c0c751a07e9 | |
| ToppCell | COVID-19_Severe-B_memory|World / disease group, cell group and cell class | 3.15e-08 | 187 | 163 | 9 | f29c71f2505bb64f3010ada491d422b87a6f7db3 | |
| ToppCell | (10)_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 3.29e-08 | 188 | 163 | 9 | fa1346902021c3a6557555ada0fd37b29cf9d5ec | |
| ToppCell | (1)_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 3.29e-08 | 188 | 163 | 9 | 642a334f2d5b6dc9df4a9fa0558833bd37bd3c58 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.29e-08 | 188 | 163 | 9 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.61e-08 | 190 | 163 | 9 | a21d0c574abf21e7cb865a21a48f29c92d055fbe | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.78e-08 | 191 | 163 | 9 | 22134a2c1a92208bc1629a620ce73a56502613c2 | |
| ToppCell | B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.78e-08 | 191 | 163 | 9 | 72e3191990973440e4f91427208df360f73e4f41 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.95e-08 | 192 | 163 | 9 | debd471f61cf3606b8e9c246add0be5df601af7f | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.95e-08 | 192 | 163 | 9 | 314f74dd3c6d94839eed05b9a1a398217ef78029 | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.95e-08 | 192 | 163 | 9 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_memory|COVID-19_Mild / Disease group, lineage and cell class | 3.95e-08 | 192 | 163 | 9 | d27db7669de95bddbea8ccb83e6f10ae7240b1ab | |
| ToppCell | mild_COVID-19-B_memory|World / disease group, cell group and cell class (v2) | 4.13e-08 | 193 | 163 | 9 | 69b70c838328fdc7dbb6b5449fe2811a5389a839 | |
| ToppCell | Club_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.13e-08 | 193 | 163 | 9 | 6582c0367052b9d10fb629c383ee0c55872afd2d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.32e-08 | 194 | 163 | 9 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.32e-08 | 194 | 163 | 9 | b6328575eedb19e0ad7f4d03041672f3dc146da0 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.32e-08 | 194 | 163 | 9 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, condition lineage and cell class | 4.72e-08 | 196 | 163 | 9 | e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-B_cells|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.14e-08 | 198 | 163 | 9 | 6231c44a909dd06f85c8210814e976a5f29148d0 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-08 | 198 | 163 | 9 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-08 | 198 | 163 | 9 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_memory|COVID-19_Mild / Disease, condition lineage and cell class | 5.37e-08 | 199 | 163 | 9 | 54e392b4ebe601d4838739ff7de3ac6b2203c948 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-B_intermediate|COVID-19_Severe / Disease, condition lineage and cell class | 5.37e-08 | 199 | 163 | 9 | ad3c369a67926725917b771094f82ca6dd2af783 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-B|COVID-19_Convalescent / Disease, condition lineage and cell class | 5.61e-08 | 200 | 163 | 9 | dfd3a2d84022cd9ae52a8182b36a9064940a56af | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.49e-08 | 150 | 163 | 8 | 17da17f01a3d41ac7df20f806e3eae30eca06982 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.49e-08 | 150 | 163 | 8 | 8702d5bb419d5e997d388e8f7e0365ba5d1de8d5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.49e-08 | 150 | 163 | 8 | 8b781ec3e6c2adf052d46d724e2aef72b0c27d13 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-07 | 159 | 163 | 8 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2) | 1.40e-07 | 160 | 163 | 8 | 6722934e153b72039c3c4308557d0ef879a30638 | |
| ToppCell | Influenza_Severe-B_memory|Influenza_Severe / Disease group and Cell class | 1.77e-07 | 165 | 163 | 8 | 51172acaeb667b34b8b8c7878d67cfa0c4a2dffc | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.85e-07 | 166 | 163 | 8 | 8de8f388f24436b84e19ef460476fdbda4d16abf | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.33e-07 | 171 | 163 | 8 | c3e3ea09c73050372314a89b282e36ba5f339d73 | |
| ToppCell | ICU-SEP-Lymphocyte-B-B_intermediate|ICU-SEP / Disease, Lineage and Cell Type | 2.33e-07 | 171 | 163 | 8 | 2e44bf6f3d90193e7cadcac48bb852bd632a81bc | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-B-Plasmablast|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.66e-07 | 174 | 163 | 8 | e8d2aa9505817aac3fe068080774d19458f07b01 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.77e-07 | 175 | 163 | 8 | 1b3510e9078eec7cfc5805043e435e9e5e0f0877 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.03e-07 | 177 | 163 | 8 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.03e-07 | 177 | 163 | 8 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 3.30e-07 | 179 | 163 | 8 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | CTRL-Lymphoid-B_cell|CTRL / Disease state, Lineage and Cell class | 3.30e-07 | 179 | 163 | 8 | dd4055c0a8360ea10323ef6249519a6ae08fc05a | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.30e-07 | 179 | 163 | 8 | 2285e3a9018a60d7f6e974fee46b6f61d39aa76f | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-07 | 179 | 163 | 8 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.30e-07 | 179 | 163 | 8 | 0b0f27d7c5cc5ae7618d887dcfa7219df8ff1935 | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.30e-07 | 179 | 163 | 8 | 63bc819df62b1f8f37bf1f17bdd4fcc161886923 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-07 | 181 | 163 | 8 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.59e-07 | 181 | 163 | 8 | 700adfb41e4e377530f0dd31be89e12f109f3469 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.59e-07 | 181 | 163 | 8 | 768d14c452192f92fa557ae59e84c43436f575f0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-07 | 181 | 163 | 8 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.74e-07 | 182 | 163 | 8 | 5f1f10c845b73d1f69794277925ef847ff23ac2d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.74e-07 | 182 | 163 | 8 | 9c120ddd109103ef6fac9c32b84d16a7624d0580 | |
| ToppCell | Leuk-UTI-Lymphocyte-B-B_memory|Leuk-UTI / Disease, Lineage and Cell Type | 3.90e-07 | 183 | 163 | 8 | f7a5daec3e8484c7071164a09e9c961fe64d9f81 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 3.90e-07 | 183 | 163 | 8 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | ICU-NoSEP-Lymphocyte-B-B_memory|ICU-NoSEP / Disease, Lineage and Cell Type | 3.90e-07 | 183 | 163 | 8 | c6d1d0779c46e08d2235b6dd342a7ec25911864c | |
| ToppCell | Mild-Lymphoid-B-|Mild / Condition, Lineage, Cell class and cell subclass | 3.90e-07 | 183 | 163 | 8 | b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 3.90e-07 | 183 | 163 | 8 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Mild-Lymphoid-B|Mild / Condition, Lineage, Cell class and cell subclass | 3.90e-07 | 183 | 163 | 8 | 9b64d2d143525e6f48a191facfd101462ff36324 | |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.90e-07 | 183 | 163 | 8 | dea119e2988e954475f557f0bbe12556a83e81a4 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.06e-07 | 184 | 163 | 8 | 64bede8db709fd32f40c03265b96f0b12155bb8a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.06e-07 | 184 | 163 | 8 | d18e94839a62fca536ae1630c154e5d0aafc44c5 | |
| ToppCell | Control-Lymphoid-B|Control / Disease state, Lineage and Cell class | 4.06e-07 | 184 | 163 | 8 | de0294f879268bfd68e91adcc2adba211d221b7a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.06e-07 | 184 | 163 | 8 | 3f8a359e40bebe58545f708682e5e5d1b70cf5cb | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 4.23e-07 | 185 | 163 | 8 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.23e-07 | 185 | 163 | 8 | 609080adb2cfb105bb7b8efb617553833299f371 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 4.23e-07 | 185 | 163 | 8 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Control-Lymphocyte-B|Control / Disease, Lineage and Cell Type | 4.23e-07 | 185 | 163 | 8 | cb61b5ff6a2ef71c94469c35cafc21df5bcf61b1 | |
| ToppCell | -IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.23e-07 | 185 | 163 | 8 | 10f7e5daf8e95dda9453212e84b64874f4e0d7ab | |
| ToppCell | COVID-19-lung-B_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.23e-07 | 185 | 163 | 8 | e8f1ad580f19705b5ca1d7d8867b2125f4891684 | |
| ToppCell | URO-Lymphocyte-B|URO / Disease, Lineage and Cell Type | 4.41e-07 | 186 | 163 | 8 | c46ff4fc280b67a454ee9614e93c6854a5a400b8 | |
| ToppCell | Mild_COVID-19-B_cell-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.41e-07 | 186 | 163 | 8 | 855a5a00ba2aa1b5c63b8db56d026ddecc546050 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.59e-07 | 187 | 163 | 8 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-B-B_memory|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.78e-07 | 188 | 163 | 8 | 8da631b2c75441b7309f03e7d4c14f15f2367be6 | |
| ToppCell | Control-Lymphoid_B-B_memory|Control / Disease group, lineage and cell class | 4.78e-07 | 188 | 163 | 8 | ba4245de3bee29118abab57c4fce60b2007a189c | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.78e-07 | 188 | 163 | 8 | 9256c5f45c97df209bb9c322c3b557d4f726a333 | |
| ToppCell | 356C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.98e-07 | 189 | 163 | 8 | 0994aba7a44577a8943af237c9c3575502d0584c | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 4.98e-07 | 189 | 163 | 8 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | Bac-SEP-Lymphocyte-B-Plasmablast|Bac-SEP / Disease, Lineage and Cell Type | 4.98e-07 | 189 | 163 | 8 | 6339b6d1056e07cefb0e1b2a0e479913c5783c8a | |
| ToppCell | 356C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.98e-07 | 189 | 163 | 8 | d1bd3b5ac32459929e556fb3a4fe8e1e15f6e658 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-07 | 190 | 163 | 8 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | Healthy_donor-B_memory|Healthy_donor / disease group, cell group and cell class (v2) | 5.18e-07 | 190 | 163 | 8 | 46104a521f00d399315deca86699cb261b2795d6 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.18e-07 | 190 | 163 | 8 | 95b9334573eefb132daaa9371377ad60232006ae | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 5.18e-07 | 190 | 163 | 8 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.40e-06 | 196 | 161 | 10 | 4535_UP | |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; MCF7; HT_HG-U133A | PLXNA3 HSPG2 LRP12 MAST2 OVGP1 FARP1 PLAGL1 PCNX1 CAPN5 SAMD4A | 1.46e-06 | 197 | 161 | 10 | 4363_DN |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A | CASS4 HSPG2 CDIP1 MAST2 NPEPL1 GREB1L OVGP1 TBC1D22A OTUD4 MRTFA | 1.53e-06 | 198 | 161 | 10 | 6742_DN |
| Drug | MDL 20,610 | 3.43e-06 | 5 | 161 | 3 | CID000128209 | |
| Drug | AC1L9LSE | 4.10e-06 | 16 | 161 | 4 | CID000448272 | |
| Drug | TAN-1030A | 6.83e-06 | 6 | 161 | 3 | CID009576886 | |
| Drug | 3,5-diaminocyclohexan-1-ol | 7.96e-06 | 67 | 161 | 6 | CID004632239 | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.12e-05 | 196 | 161 | 9 | 4252_UP | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; HL60; HT_HG-U133A | 1.12e-05 | 196 | 161 | 9 | 3083_UP | |
| Drug | Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.16e-05 | 197 | 161 | 9 | 6737_DN | |
| Drug | AC1MHTIN | 1.19e-05 | 7 | 161 | 3 | CID003011133 | |
| Drug | TAN-999 | 1.19e-05 | 7 | 161 | 3 | CID000130283 | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 1.21e-05 | 198 | 161 | 9 | 2768_UP | |
| Drug | Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.21e-05 | 198 | 161 | 9 | 7357_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.26e-05 | 199 | 161 | 9 | 5540_UP | |
| Drug | Intravenous Immunoglobulin | 1.89e-05 | 8 | 161 | 3 | DB00028 | |
| Drug | AC1NSK5W | 2.83e-05 | 9 | 161 | 3 | CID005311182 | |
| Drug | Palivizumab | 4.02e-05 | 10 | 161 | 3 | DB00110 | |
| Drug | Denny-Jaffe reagent | 4.02e-05 | 10 | 161 | 3 | CID003035979 | |
| Drug | Contact Lens Solutions | 4.97e-05 | 2 | 161 | 2 | ctd:D018639 | |
| Drug | Bevacizumab | 5.49e-05 | 11 | 161 | 3 | DB00112 | |
| Drug | Tositumomab | 5.49e-05 | 11 | 161 | 3 | DB00081 | |
| Drug | Alemtuzumab | 5.49e-05 | 11 | 161 | 3 | DB00087 | |
| Drug | Efalizumab | 5.49e-05 | 11 | 161 | 3 | DB00095 | |
| Drug | Alefacept | 5.49e-05 | 11 | 161 | 3 | DB00092 | |
| Drug | Anisomycin [22862-76-6]; Down 200; 15uM; PC3; HT_HG-U133A | 5.74e-05 | 187 | 161 | 8 | 6764_DN | |
| Drug | AC1L9INI | 6.11e-05 | 59 | 161 | 5 | CID000445839 | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 6.66e-05 | 191 | 161 | 8 | 7376_DN | |
| Drug | Daclizumab | 7.29e-05 | 12 | 161 | 3 | DB00111 | |
| Drug | Natalizumab | 7.29e-05 | 12 | 161 | 3 | DB00108 | |
| Drug | Rituximab | 7.29e-05 | 12 | 161 | 3 | DB00073 | |
| Drug | Ibritumomab | 7.29e-05 | 12 | 161 | 3 | DB00078 | |
| Drug | Adalimumab | 7.29e-05 | 12 | 161 | 3 | DB00051 | |
| Drug | Gemtuzumab ozogamicin | 7.29e-05 | 12 | 161 | 3 | DB00056 | |
| Drug | Cetuximab | 7.29e-05 | 12 | 161 | 3 | DB00002 | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 7.43e-05 | 194 | 161 | 8 | 2223_UP | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A | 7.43e-05 | 194 | 161 | 8 | 6516_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; PC3; HT_HG-U133A | 7.70e-05 | 195 | 161 | 8 | 7394_UP | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; HL60; HG-U133A | 7.98e-05 | 196 | 161 | 8 | 2044_DN | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 7.98e-05 | 196 | 161 | 8 | 2103_DN | |
| Drug | Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; PC3; HT_HG-U133A | 7.98e-05 | 196 | 161 | 8 | 5861_DN | |
| Drug | Ioxaglic acid [59017-64-0]; Up 200; 3.2uM; MCF7; HT_HG-U133A | 7.98e-05 | 196 | 161 | 8 | 7470_UP | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; PC3; HT_HG-U133A | 8.27e-05 | 197 | 161 | 8 | 6741_DN | |
| Drug | SB 203580; Up 200; 1uM; PC3; HT_HG-U133A | 8.27e-05 | 197 | 161 | 8 | 7066_UP | |
| Drug | Apramycin [37321-09-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 8.27e-05 | 197 | 161 | 8 | 7334_UP | |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 2841_UP | |
| Drug | genistein; Down 200; 10uM; PC3; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 1235_DN | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; PC3; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 6656_UP | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 4592_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 8.87e-05 | 199 | 161 | 8 | 4316_DN | |
| Drug | Furazolidone [67-45-8]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 8.87e-05 | 199 | 161 | 8 | 4178_UP | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; HL60; HT_HG-U133A | 8.87e-05 | 199 | 161 | 8 | 2987_DN | |
| Drug | Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 8.87e-05 | 199 | 161 | 8 | 6075_DN | |
| Drug | Trastuzumab | 9.42e-05 | 13 | 161 | 3 | DB00072 | |
| Drug | Basiliximab | 9.42e-05 | 13 | 161 | 3 | DB00074 | |
| Drug | Abciximab | 1.19e-04 | 14 | 161 | 3 | DB00054 | |
| Drug | Etanercept | 1.19e-04 | 14 | 161 | 3 | DB00005 | |
| Drug | cellobiitol | 1.33e-04 | 37 | 161 | 4 | CID000003871 | |
| Drug | Muromonab | 1.48e-04 | 15 | 161 | 3 | DB00075 | |
| Drug | Uranium pentafluoride | 1.48e-04 | 3 | 161 | 2 | CID003014661 | |
| Drug | Boric Acids | 1.48e-04 | 3 | 161 | 2 | ctd:D001888 | |
| Disease | red blood cell density measurement | RALGAPA1 HNF1A ZBTB16 BCAS3 PKP4 MECOM PSMD2 MAST2 ZNF106 FCGR2C DST FCGR2B ZNF827 OTUD4 RAI14 MAML2 MBD2 MUC4 KIF11 | 4.09e-07 | 880 | 162 | 19 | EFO_0007978 |
| Disease | cholangiocarcinoma (is_marker_for) | 1.44e-06 | 64 | 162 | 6 | DOID:4947 (is_marker_for) | |
| Disease | FEV/FEC ratio | HSPG2 DCHS2 BCAS3 PCDHGA1 CDH23 MECOM DCC ZNF106 FCGR2C DST HMCN1 FCGR2A FCGR2B EPC1 OTUD4 RIPOR1 RAI14 MTCL1 MAML2 MBD2 MRTFA | 4.05e-06 | 1228 | 162 | 21 | EFO_0004713 |
| Disease | malaria (implicated_via_orthology) | 1.33e-05 | 9 | 162 | 3 | DOID:12365 (implicated_via_orthology) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.18e-05 | 61 | 162 | 5 | DOID:3587 (is_marker_for) | |
| Disease | neural cell adhesion molecule 1 measurement | 3.00e-05 | 2 | 162 | 2 | EFO_0801826 | |
| Disease | insulin growth factor-like family member 4 measurement | 3.00e-05 | 2 | 162 | 2 | EFO_0801701 | |
| Disease | immunoglobulin G measurement | 3.00e-05 | 2 | 162 | 2 | EFO_0020465 | |
| Disease | Colorectal Carcinoma | EPHB6 ABCC5 CUBN DCC CBFA2T3 LRRC4 CSMD3 SPACA7 OVGP1 MKI67 DCHS1 LRP2 CTNND2 SMAD4 | 3.55e-05 | 702 | 162 | 14 | C0009402 |
| Disease | pack-years measurement, systolic blood pressure | 3.57e-05 | 34 | 162 | 4 | EFO_0006335, EFO_0006526 | |
| Disease | mean platelet volume | ZBTB16 TTC28 PCDHGA1 ABCC5 MECOM PSMD2 IRAG1 CBFA2T3 MLXIPL BRD8 KCNE4 BAZ2A EPC1 LINC00208 RIPOR1 MAML2 MRTFA | 4.92e-05 | 1020 | 162 | 17 | EFO_0004584 |
| Disease | osteoporosis | 5.21e-05 | 73 | 162 | 5 | EFO_0003882 | |
| Disease | asthma | CYLD SUSD6 FSIP1 MUC16 MECOM IRAG1 CSMD3 SLC9A4 STARD3 MROH7 ZNF76 CTNND2 KIF11 SMAD4 | 7.30e-05 | 751 | 162 | 14 | MONDO_0004979 |
| Disease | ameloblastin measurement | 8.95e-05 | 3 | 162 | 2 | EFO_0801377 | |
| Disease | paired immunoglobulin-like type 2 receptor alpha measurement | 8.95e-05 | 3 | 162 | 2 | EFO_0801866 | |
| Disease | secretoglobin family 1C member 1 measurement | 8.95e-05 | 3 | 162 | 2 | EFO_0802041 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 1.04e-04 | 17 | 162 | 3 | EFO_0021969 | |
| Disease | urate measurement | NCOA6 HNF1A FSIP1 BCAS3 MECOM C11orf24 CUBN MLXIPL ZNF827 GLI1 LRP2 TMF1 RAI14 MUC1 PRRC2B | 1.31e-04 | 895 | 162 | 15 | EFO_0004531 |
| Disease | p-tau:beta-amyloid 1-42 ratio measurement | 1.48e-04 | 19 | 162 | 3 | EFO_0007709 | |
| Disease | di-N-acetylchitobiase measurement | 1.78e-04 | 4 | 162 | 2 | EFO_0801524 | |
| Disease | trem-like transcript 4 protein measurement | 1.78e-04 | 4 | 162 | 2 | EFO_0802160 | |
| Disease | sodium/potassium-transporting ATPase subunit alpha-1 measurement | 1.78e-04 | 4 | 162 | 2 | EFO_0802077 | |
| Disease | RING finger protein 165 measurement | 1.78e-04 | 4 | 162 | 2 | EFO_0802027 | |
| Disease | pancreatic cancer (is_marker_for) | 2.43e-04 | 101 | 162 | 5 | DOID:1793 (is_marker_for) | |
| Disease | platelet component distribution width | ABCC5 MECOM PSMD2 CUBN MLXIPL BRD8 KCNE4 AFAP1L2 FCGR2B BAZ2A EPC1 LINC00208 BRWD1 | 2.87e-04 | 755 | 162 | 13 | EFO_0007984 |
| Disease | potassium voltage-gated channel subfamily E member 2 measurement | 2.96e-04 | 5 | 162 | 2 | EFO_0801901 | |
| Disease | Myositis, Proliferative | 2.96e-04 | 5 | 162 | 2 | C0544796 | |
| Disease | mucositis (biomarker_via_orthology) | 2.96e-04 | 5 | 162 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | Infectious Myositis | 2.96e-04 | 5 | 162 | 2 | C0158353 | |
| Disease | protein shisa-3 homolog measurement | 2.96e-04 | 5 | 162 | 2 | EFO_0801964 | |
| Disease | Myositis | 2.96e-04 | 5 | 162 | 2 | C0027121 | |
| Disease | Myositis, Focal | 2.96e-04 | 5 | 162 | 2 | C0751357 | |
| Disease | Idiopathic Inflammatory Myopathies | 2.96e-04 | 5 | 162 | 2 | C0751356 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 3.36e-04 | 60 | 162 | 4 | C4722327 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-b measurement | 3.42e-04 | 25 | 162 | 3 | EFO_0021970 | |
| Disease | birth weight | 3.79e-04 | 399 | 162 | 9 | EFO_0004344 | |
| Disease | blood phosphate measurement | 4.13e-04 | 174 | 162 | 6 | EFO_0010972 | |
| Disease | chronic myeloid leukemia (is_marker_for) | 4.31e-04 | 27 | 162 | 3 | DOID:8552 (is_marker_for) | |
| Disease | forced expiratory volume | NCOA6 ZBTB16 BCAS3 MECOM DCC ZHX2 SLC9A4 DST OTUD4 MTCL1 CTNND2 MUC1 PRRC2B | 4.36e-04 | 789 | 162 | 13 | EFO_0004314 |
| Disease | SYSTEMIC LUPUS ERYTHEMATOSUS | 4.43e-04 | 6 | 162 | 2 | 152700 | |
| Disease | carcinoembryonic antigen-related cell adhesion molecule 1 measurement | 4.43e-04 | 6 | 162 | 2 | EFO_0801456 | |
| Disease | beta-sarcoglycan measurement | 4.43e-04 | 6 | 162 | 2 | EFO_0801422 | |
| Disease | multiple coagulation factor deficiency protein 2 measurement | 4.43e-04 | 6 | 162 | 2 | EFO_0801810 | |
| Disease | complement C1q subcomponent measurement | 4.43e-04 | 6 | 162 | 2 | EFO_0008089 | |
| Disease | vital capacity | HSPG2 NCOA6 ZBTB16 FSIP1 MECOM DCC PKD1L3 ZHX2 ZNF106 DST HMCN1 LRP2 OTUD4 RIPOR1 MTCL1 MUC1 SAMD4A | 4.76e-04 | 1236 | 162 | 17 | EFO_0004312 |
| Disease | aortic measurement | 4.94e-04 | 251 | 162 | 7 | EFO_0020865 | |
| Disease | Prostate cancer, familial | 5.73e-04 | 69 | 162 | 4 | C2931456 | |
| Disease | uric acid measurement | HNF1A FSIP1 BCAS3 MECOM CUBN MLXIPL ZNF827 LRP2 RAI14 MUC1 PRRC2B | 5.79e-04 | 610 | 162 | 11 | EFO_0004761 |
| Disease | neutrophil count | HNF1A ZBTB16 TTC28 CDH23 ABCC5 MECOM PSMD2 CBFA2T3 MAST2 MEF2D MLXIPL FCGR2B RP1L1 STARD3 LINC00208 PLAGL1 MUC22 MBD2 | 6.13e-04 | 1382 | 162 | 18 | EFO_0004833 |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a/b measurement | 6.18e-04 | 7 | 162 | 2 | EFO_0008211 | |
| Disease | inducible T-cell costimulator measurement | 6.18e-04 | 7 | 162 | 2 | EFO_0021967 | |
| Disease | Headache, HOMA-B | 6.18e-04 | 7 | 162 | 2 | EFO_0004469, HP_0002315 | |
| Disease | lymphoid leukemia (is_implicated_in) | 6.18e-04 | 7 | 162 | 2 | DOID:1037 (is_implicated_in) | |
| Disease | myeloid white cell count | HNF1A ZBTB16 TTC28 CDH23 ABCC5 MECOM PSMD2 MAST2 MLXIPL FCGR2A FCGR2B LINC00208 RAI14 MBD2 | 6.90e-04 | 937 | 162 | 14 | EFO_0007988 |
| Disease | Sarcomatoid Renal Cell Carcinoma | 7.21e-04 | 128 | 162 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 7.21e-04 | 128 | 162 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 7.21e-04 | 128 | 162 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 7.21e-04 | 128 | 162 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 7.21e-04 | 128 | 162 | 5 | C0007134 | |
| Disease | response to vaccine, cytokine measurement | 8.00e-04 | 131 | 162 | 5 | EFO_0004645, EFO_0004873 | |
| Disease | platelet crit | CASS4 ZBTB16 TTC28 SUSD6 BCAS3 ABCC5 MECOM CUBN MEF2D DCHS1 OTUD4 ZNF76 SMAD4 SAMD4A | 8.05e-04 | 952 | 162 | 14 | EFO_0007985 |
| Disease | common bile duct neoplasm (is_marker_for) | 8.21e-04 | 8 | 162 | 2 | DOID:4608 (is_marker_for) | |
| Disease | eotaxin measurement | 1.00e-03 | 80 | 162 | 4 | EFO_0008122 | |
| Disease | plexin-B2 measurement | 1.05e-03 | 9 | 162 | 2 | EFO_0021867 | |
| Disease | creatinine measurement | HNF1A ZBTB16 BCAS3 MECOM PSMD2 CUBN PKD1L3 MAST2 BRWD3 ARG1 SLC9A4 LRP2 MUC1 MRTFA | 1.23e-03 | 995 | 162 | 14 | EFO_0004518 |
| Disease | lung adenocarcinoma (is_marker_for) | 1.25e-03 | 85 | 162 | 4 | DOID:3910 (is_marker_for) | |
| Disease | information processing speed | 1.25e-03 | 85 | 162 | 4 | EFO_0004363 | |
| Disease | axin-2 measurement | 1.31e-03 | 10 | 162 | 2 | EFO_0801400 | |
| Disease | beta-defensin 1 measurement | 1.31e-03 | 10 | 162 | 2 | EFO_0801415 | |
| Disease | dry eye syndrome (is_marker_for) | 1.31e-03 | 10 | 162 | 2 | DOID:10140 (is_marker_for) | |
| Disease | otitis media (is_marker_for) | 1.31e-03 | 10 | 162 | 2 | DOID:10754 (is_marker_for) | |
| Disease | allergic conjunctivitis (is_marker_for) | 1.31e-03 | 10 | 162 | 2 | DOID:11204 (is_marker_for) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.38e-03 | 148 | 162 | 5 | C0279702 | |
| Disease | basophil count | ZBTB16 PSMD2 FCGR2C SLC9A4 FCGR2A FCGR2B HELZ2 LINC00208 MUC22 | 1.46e-03 | 483 | 162 | 9 | EFO_0005090 |
| Disease | white matter microstructure measurement | 1.47e-03 | 390 | 162 | 8 | EFO_0005674 | |
| Disease | alkaline phosphatase measurement | RALGAPA1 HSPG2 HNF1A PKD1L3 NPEPL1 MLXIPL FCGR2C FCGR2B ZNF827 ATF7IP RP1L1 LINC00208 RAI14 MUC22 | 1.48e-03 | 1015 | 162 | 14 | EFO_0004533 |
| Disease | aspartate aminotransferase measurement | HNF1A TTC28 CUBN MEF2D FCGR2C FCGR2A FCGR2B ZNF827 BAZ2A IGHG1 IGHG3 GLI1 SAMD4A | 1.51e-03 | 904 | 162 | 13 | EFO_0004736 |
| Disease | Multiple Myeloma | 1.59e-03 | 42 | 162 | 3 | C0026764 | |
| Disease | Systemic lupus erythematosus | 1.59e-03 | 11 | 162 | 2 | cv:C0024141 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.60e-03 | 153 | 162 | 5 | EFO_0004611, EFO_0020946 | |
| Disease | heart rate response to exercise | 1.71e-03 | 43 | 162 | 3 | EFO_0009184 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 1.71e-03 | 43 | 162 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | Craniofacial Abnormalities | 1.74e-03 | 156 | 162 | 5 | C0376634 | |
| Disease | immunoglobulin isotype switching measurement | 1.82e-03 | 44 | 162 | 3 | EFO_0010128 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.91e-03 | 12 | 162 | 2 | C0023485 | |
| Disease | chronic kidney disease | 1.95e-03 | 235 | 162 | 6 | EFO_0003884 | |
| Disease | oropharynx cancer | 2.07e-03 | 46 | 162 | 3 | EFO_1001931 | |
| Disease | systolic blood pressure, alcohol consumption measurement | 2.21e-03 | 47 | 162 | 3 | EFO_0006335, EFO_0007878 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 2.25e-03 | 13 | 162 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 2.25e-03 | 13 | 162 | 2 | C1846647 | |
| Disease | tumor necrosis factor ligand superfamily member 11 measurement | 2.25e-03 | 13 | 162 | 2 | EFO_0010617 | |
| Disease | retinal vasculature measurement | 2.31e-03 | 517 | 162 | 9 | EFO_0010554 | |
| Disease | cognitive function measurement | LVRN TTC28 ABCC5 PSMD2 FPGT DCC PKD1L3 CDH19 CSMD3 SLC9A4 TBC1D22A FARP1 ATF7IP TMEM131 IGSF9B CTNND2 MRTFA | 2.37e-03 | 1434 | 162 | 17 | EFO_0008354 |
| Disease | coronary artery disease | NCOA6 HNF1A BCAS3 MECOM IRAG1 PKD1L3 AFAP1L2 ZNF827 FARP1 PAX5 TBX20 MUC22 MUC1 PRDM6 MRTFA | 2.49e-03 | 1194 | 162 | 15 | EFO_0001645 |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.54e-03 | 103 | 162 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | monocyte count | RALGAPA1 ZBTB16 BCAS3 CDH23 MECOM PSMD2 IRAG1 MAST2 MEF2D MLXIPL FCGR2C SLC9A4 FCGR2B PLAGL1 MUC22 MRTFA | 2.56e-03 | 1320 | 162 | 16 | EFO_0005091 |
| Disease | Pneumoconiosis | 2.61e-03 | 14 | 162 | 2 | C0032273 | |
| Disease | Bagassosis | 2.61e-03 | 14 | 162 | 2 | C0004681 | |
| Disease | suicide | 2.64e-03 | 50 | 162 | 3 | EFO_0007624 | |
| Disease | mean arterial pressure, alcohol consumption measurement | 2.95e-03 | 52 | 162 | 3 | EFO_0006340, EFO_0007878 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALSTLTNTVIVPHSG | 656 | Q99569 | |
| SQSSLIHLVGPSDCT | 226 | O00154 | |
| YPTVSTISLGSHTVL | 121 | Q3KRA9 | |
| SVNLQVSPGSLTFHS | 56 | Q96KT6 | |
| NLAPSLTTLSHGTTT | 286 | Q9UMD9 | |
| GLHLSSTTPTALVHT | 696 | Q9H2F5 | |
| HTATVLVPSGAATTV | 111 | Q9H305 | |
| SHTGESLPLATSNQV | 1691 | Q7Z408 | |
| PTQQSSLLSSLSGSH | 1821 | Q7Z407 | |
| HGSLSSSQPAEIITQ | 691 | Q9NQ75 | |
| ATLQSHTLADSIPSS | 676 | Q9H0E9 | |
| VSSNLHGSTPQVTVE | 361 | Q6QNK2 | |
| NGLSTVSHTTTSGIL | 56 | Q9UIF9 | |
| TGQTSLSDPVHLTVL | 106 | P12318 | |
| GQTSLSDPVHLTVLS | 116 | P31994 | |
| PVTLGTTVDTTHLEN | 751 | Q8N4X5 | |
| SVTNSTHSLLPGTEN | 116 | Q13489 | |
| PVAVLQGHSASITSI | 256 | Q6RI45 | |
| SNLPGTVAVHILSST | 621 | O15484 | |
| THQSGFPVITLNVST | 571 | Q6Q4G3 | |
| TVISSSSSVLQSHGP | 756 | Q9H6U6 | |
| GTPTKSSTSTLTIHV | 971 | Q9H251 | |
| TSGSASHLQATAPLL | 286 | Q07687 | |
| ISSSPIHQLSSTIGT | 341 | Q9UQB3 | |
| HTDINTPLTTTSGNL | 126 | P05089 | |
| AQKTPVHATTSLTLG | 31 | Q96IT6 | |
| SATSGILGTTHITEP | 2216 | Q9HC84 | |
| ILGTTHITEPSTVTS | 2221 | Q9HC84 | |
| SGILGTTHITEPSTV | 3476 | Q9HC84 | |
| TASSTLGTAHTPKVV | 4866 | Q9HC84 | |
| SHGTLIPDTNETITL | 236 | Q68CQ1 | |
| SKAGVSQLLPSTSIH | 151 | Q09MP3 | |
| SSPSVLIHSLGKSTT | 411 | Q9P0K7 | |
| TLTTGPDSAVSQAHL | 621 | Q01804 | |
| HVQASGTLSAPVVSI | 1856 | P98160 | |
| ESPVHTTINDGLSSL | 1751 | Q9Y4B5 | |
| VPASSHSIVSTGSVT | 151 | Q02548 | |
| TAGIQATSPLTTVHT | 781 | Q9HCM3 | |
| TSSPHSELESTGAIL | 1001 | Q03112 | |
| AHGVQTESSTVTPTL | 836 | P00450 | |
| TPLLSASVTGHTNIV | 216 | Q96JP0 | |
| GHTKISTSIPLLSSA | 716 | Q8WXI7 | |
| STGSALPKISHLTGT | 931 | Q8WXI7 | |
| STGTIEQSTQPLHAV | 1976 | Q8WXI7 | |
| HATTSPSNILLTSQG | 4166 | Q8WXI7 | |
| LQGQHTSSPVSATSV | 4471 | Q8WXI7 | |
| HSTLPLDTSTTLSQG | 5281 | Q8WXI7 | |
| HSSSASVTSLLTPGQ | 7416 | Q8WXI7 | |
| SSASTGHATPLLVTD | 1191 | Q99102 | |
| GHATPLLVTDTSSAS | 1196 | Q99102 | |
| ASTGHATPLLVTDTS | 1401 | Q99102 | |
| SSASTGHATPLLVTD | 2071 | Q99102 | |
| HAIPLLVTDTSSAST | 2221 | Q99102 | |
| TRLPVTNVSSASTGH | 2431 | Q99102 | |
| SSVSTGHTTPLLVTD | 2471 | Q99102 | |
| GHTTPLLVTDASSVS | 2476 | Q99102 | |
| SSASTGHATPLLVTD | 2631 | Q99102 | |
| VTNTSSVSTGHATPL | 2771 | Q99102 | |
| DTSSASTGHATLLPV | 2981 | Q99102 | |
| STGHATLLPVTDTSS | 2986 | Q99102 | |
| TLLPVTDTSSASIGH | 2991 | Q99102 | |
| ASIGHATSLPVTDTS | 3001 | Q99102 | |
| VTDTSSISTGHATPL | 3011 | Q99102 | |
| SSASTGHATPLLVTD | 3191 | Q99102 | |
| PLLVTETSSVSTGHA | 3296 | Q99102 | |
| ETSSVSTGHATPLLV | 3301 | Q99102 | |
| STGHATPLLVTDASS | 3306 | Q99102 | |
| TPLLVTDASSASTGH | 3311 | Q99102 | |
| SSASTGHATPLLVTD | 3751 | Q99102 | |
| VTNASSLSTGHATPL | 4051 | Q99102 | |
| HVDPTTGTITTTAIL | 2221 | Q96JQ0 | |
| LTPVSHSQSETQLGS | 1186 | P43146 | |
| QEPVSASTHIASSLG | 971 | P52948 | |
| IGNTSALPHTLLTAS | 151 | Q9Y585 | |
| TPVTAVSVHLLSSNG | 201 | Q5VUB5 | |
| VSVHLLSSNGTPVLV | 206 | Q5VUB5 | |
| VSSESSSPDVHLTIQ | 176 | Q8WWG9 | |
| DSHAPLTVVSSSGQI | 336 | Q9Y561 | |
| TLASLLQSSHESPQS | 786 | O60732 | |
| SAGTLLTTPQHTAIG | 206 | Q92567 | |
| QFATPHSATTTTLAL | 2386 | Q2M2H8 | |
| SHTSLAPTNLSNLGT | 2401 | Q2M2H8 | |
| ASAASHTVPGIVLNT | 1581 | E2RYF6 | |
| IGTATTHLSPELAAQ | 661 | Q96T76 | |
| AQTLHPSLTSGLTQS | 511 | Q03001 | |
| LGSLTSIPENVSTHV | 586 | P52732 | |
| GHLASSVLISTTQPV | 1716 | Q5HYC2 | |
| TLVHNGTSARATTTP | 971 | P15941 | |
| VSTASLTSVDPAGHI | 116 | Q9Y6F6 | |
| GQTSLSDPVHLTVLS | 116 | P31995 | |
| VQHGLPSSSSSSQSI | 2186 | Q96RV3 | |
| NGSTAITVSGTHLLT | 1036 | P51805 | |
| TNTIHTTAESALAPT | 1311 | Q02505 | |
| LHTLTPSTALSTIVS | 2611 | Q02505 | |
| LAVLSHTPDGATQTI | 241 | Q8NDH3 | |
| NSLGNSLHPTVTTIS | 621 | Q9HBW1 | |
| STLTALHSLEQTSPG | 381 | P20823 | |
| SESGLHTPASQATTL | 551 | P20823 | |
| TESHTSNLGSQVPLA | 601 | Q8NG31 | |
| GLKLPSLSHTGTTVS | 516 | P08151 | |
| SSLVPSLHITTLGQE | 171 | Q6ZVL6 | |
| ISYATLSSGIHTPTV | 2446 | P98164 | |
| LSSGIHTPTVIASGI | 2451 | P98164 | |
| LTRTSGETTQTHTEP | 2501 | P46013 | |
| VHLTTTLEEHSSGTP | 116 | Q6UWI2 | |
| ALAPQVLGHTTDSVT | 676 | Q13219 | |
| GPATSSTASLSTQHL | 151 | O75081 | |
| LTSVISGSLSHSEPS | 786 | Q9C091 | |
| LHTGLSNNITISPVT | 71 | Q9H7L2 | |
| TITNSGSHPTEIIVT | 2291 | Q96RW7 | |
| LSEPTAHEGSTVTVS | 321 | P32942 | |
| NSTVTLSHPNGTTSV | 181 | P41217 | |
| LSHPNGTTSVTSILH | 186 | P41217 | |
| ESTPLGSHITVVSAN | 2676 | Q6V1P9 | |
| QRVLASPTSTSQLHS | 451 | Q9NQX0 | |
| ILTPNSSLLSTSHGT | 841 | Q8IZL2 | |
| ITTSANTSAALPTHL | 1606 | Q14686 | |
| ASALHTSSAPITGQV | 326 | Q9UBB5 | |
| TQSPFLSHITSSIQG | 1046 | O15440 | |
| SSLLEAPQGHTITLT | 2716 | O60494 | |
| GHLTAPDTTVTVSIA | 136 | Q9NZI5 | |
| SAPSHSTSLLQGLAT | 41 | Q53HC5 | |
| FLIPTSLSVSSNSVH | 401 | Q6AI39 | |
| TGSLTGSPHLSELSV | 471 | Q9Y4F1 | |
| LQGHTGSITSLQFSP | 266 | Q9NSI6 | |
| LGTTLAVQAVPTAHS | 866 | Q6VMQ6 | |
| QLLPLSSSVHSSVGQ | 111 | Q6P0Q8 | |
| GEPSLSSTTTVHVDV | 251 | Q8IXH8 | |
| LSLTAVSEETVGPSH | 176 | Q8NA03 | |
| LTSGVHTFPAVLQSS | 46 | P01857 | |
| LTSGVHTFPAVLQSS | 46 | P01859 | |
| LTSGVHTFPAVLQSS | 46 | P01860 | |
| LTSGVHTFPAVLQSS | 46 | P01861 | |
| GSIGHSPLSLSAQSV | 431 | Q9NQC7 | |
| VLSTVHTCQSLLSPG | 871 | Q9BYK8 | |
| HALGNPELSVSSVST | 536 | O94829 | |
| GIPSLTSTNTLTIHV | 556 | Q9H159 | |
| LALHTQSSETAGSPS | 371 | Q6PJW8 | |
| FTALAHPSSLTIGTT | 201 | O14772 | |
| QRLGVSQSTHSLTTP | 296 | Q14814 | |
| SLPLSISTTEAVSFH | 666 | Q13029 | |
| LSAAVSGVPHIVQTS | 181 | Q12889 | |
| LAVAGIHSLPSTSVT | 96 | O75928 | |
| DQGTPALSTETHISL | 426 | Q9Y5H4 | |
| LTSIPVSHTLVANSE | 2281 | Q685J3 | |
| ELPSATHSGQATAVL | 546 | Q8NBS3 | |
| STASTLSTPLHAGID | 71 | Q96KW9 | |
| LQTGDLLSTFHTISP | 216 | Q9UM63 | |
| HLSQSPSVSQLSVLS | 341 | P78395 | |
| SPGSSHTILATTAAQ | 701 | Q6IEE7 | |
| TITGFQTHTTPVLLA | 861 | Q13200 | |
| SLGSPTLQATHSFLT | 616 | Q9H6K5 | |
| ETNTATVTQLSPGHI | 541 | O15197 | |
| SLITAITTNGAHPSK | 56 | Q13485 | |
| VTHAGQSLAETTSSP | 241 | Q7Z443 | |
| TGILSSTAFSIPHQA | 561 | Q6AI14 | |
| HPTTCTISDLIIGNS | 321 | Q13203 | |
| HTSLGVPTLSIVAST | 111 | Q92537 | |
| TLHGLVSTLSAQPSL | 671 | Q9NP71 | |
| PTLITDSTGTHLVLT | 656 | Q969V6 | |
| LPAVASLGSSLSHSQ | 16 | Q14849 | |
| SLVHGLTLVGTSSNP | 86 | Q8NBQ7 | |
| PTVLSSGSTIHSIAL | 431 | Q9UQC9 | |
| HSSSEETSSVLQPGI | 36 | Q16281 | |
| TATGHPSLSTALAQV | 181 | Q96F05 | |
| QISITSTTLLPHSGD | 576 | Q9UBH6 | |
| STTLLPHSGDIIATV | 581 | Q9UBH6 | |
| SLHIGQSRTPETTES | 136 | P82094 | |
| ALLPSTSQHTGDLTS | 681 | Q5T6F2 | |
| HLSGTVTELATASEP | 201 | Q9P217 | |
| ASSPLLITSDTEHVT | 1451 | Q7Z2Z1 | |
| SVTSGLHVQPALAVS | 351 | Q05516 | |
| TSSLQSSDAVIIHPG | 836 | Q8IZQ1 | |
| IATITHLLPSTEASS | 1366 | Q6GYQ0 | |
| DLLGTSSATVTPAVH | 731 | Q8IWN7 | |
| TSDLHTPGTQLSVAD | 6 | A0PJK1 | |
| SITASTHLTVIGTSP | 496 | Q9UPX0 | |
| SPLVLDSNTVTQGHT | 1261 | Q92545 | |
| HIISATSLSTSPTEL | 216 | Q5JSZ5 | |
| AGFSTLSQVPSLSHT | 1201 | O94885 | |
| LSSVILSHDSSQVPN | 261 | Q86V40 | |
| TVCVLALPTTTGSAH | 751 | Q9NNW5 | |
| QSLPHSATVTLGGTS | 166 | Q8WUA7 | |
| LSTSPITVCHGSGIS | 276 | O75569 | |
| TGISPSSSGVHLIQA | 101 | Q0VFX4 | |
| LGSTTPSSHTLELVA | 71 | Q17R98 | |
| IETTNHVVSITTSGP | 156 | Q9Y6X8 | |
| SVTLPTATGSALEQH | 1281 | Q96AY4 | |
| LSSQSSPIHSSTVDG | 331 | Q86YA3 | |
| HPQSLTALGTSTASI | 361 | Q9UMR3 | |
| LQLTTTITHVDGPTE | 516 | Q5T9L3 | |
| IHSSSFPGVTVINLT | 606 | O60294 | |
| NPHTVTLDLSSLSAG | 671 | O60294 | |
| GSTHKPIISTLTTTG | 576 | Q6ZS17 | |
| LQITTSPTFQTHGSV | 1176 | Q9H2Y7 | |
| TIGTSTSTILSGQAH | 231 | Q9UPU9 | |
| VTQHGSTTLTIPSPD | 461 | P36508 | |
| TISTIAATVTAPHSE | 96 | Q6UXF1 | |
| ITDTHTPSGLTVNLT | 351 | Q8IYS2 | |
| ASGLLEASTPVHSST | 1796 | Q9UKN1 | |
| SHSSQDATGTIVLPA | 1996 | Q9UKN1 | |
| ITSGLVEASTPTHSS | 3101 | Q9UKN1 | |
| TTASGLLEASTPVHS | 3351 | Q9UKN1 | |
| ASGLLEASTPVHSST | 4436 | Q9UKN1 | |
| SHSSQDATGTIVLPA | 4636 | Q9UKN1 | |
| THTVLPATLTTTDIG | 5031 | Q9UKN1 | |
| QSSAVLLHSGSSVPA | 16 | Q9BRK3 | |
| GQESTATVTPHTLQV | 476 | O15069 | |
| ISSQTHVPILSISGG | 111 | Q14957 |